Researchers at Stanford have developed a gene expression-based method for determining a virally infected patient's risk of developing severe symptoms, irrespective of the virus.
Stanford researchers at the Dionne Lab have developed a new hand-held technology that uses optical characterization to rapidly and quantitatively measure extracted viral-RNA target binding or antibody binding to nanofabricated platforms.